← Evidence map

ArticleCancers2023

SRSF5 Regulates the Expression of BQ323636.1 to Modulate Tamoxifen Resistance in ER-Positive Breast Cancer.

Ho Tsoi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2023
2024
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 37190199